The Motley Fool··Prosper Junior BakinyCan Eli Lilly Become First $2T Healthcare Giant? Three Growth Catalysts in Focus
Eli Lilly eyes $2 trillion valuation from weight-loss drugs, Alzheimer's breakthroughs, and AI-powered R&D following recent market pullback.
PFENVDALLYREGNhealthcare stocksweight loss drugs